Pre Seed · Biotech · Stockholm, Sweden · Founded 2023 · 2–5 employees
NEXUS Epigenomics AB is a Swedish biotech startup building a versatile, plug-and-play platform of technologies to profile multiple layers of the epigenome, enabling researchers to efficiently target specific segments of gene regulation. A flagship product focuses on DNA methylation, utilizing proprietary technology for cost-effective, data-rich genome-wide methylation pattern capture with single-cell resolution. The company is founded by Dr. Mukund Kabbe (CEO) and Jana Lalakova (COO), both with deep expertise rooted in research at the Karolinska Institutet. NEXUS is backed by SU Holding and DRIVE (KI Innovations Business Incubator) and has received a European Commission Horizon grant (€105,000) for its MeTLAND methylation profiling project, positioning it at the forefront of accessible epigenomic research tools.
No open roles listed right now.